Живот за Ники Life for Nikki

Treatment, Medicine and Rehabilitation 0/0
3048 Donors
120216.47 EUR donated from 127823 EUR
End date
Ends in 10 days
Available amount
76369.68 EUR
Николай Колев is the organiser of the campaign
Ends in 10 days
Available amount
76369.68 EUR

Одобрено изплащане Одобрено изплащане

20th May 2024
Ники беше преместен от Франкфурт в специализирана онкологична клиника занимаваща се със специфичните тумори саркоми. Болницата е Haidelberg University Hospital и една от най-добрите клиники в Европа. На 1.05 беше направена успешно биопсия, от която бяха взети няколко проби. Резултатът от биопсията показа, че туморът е Сарком на Юнг, един от най-агресивните саркоми. Поставеното му лечение включва 9 химиотерапии, последвани от операция за отстраняване и след това още 6 вливания. Процедурите започнаха на 17.05.2024 г. Nikki was transferred from Frankfurt to a specialised oncology clinic dealing with specific sarcoma tumours. The hospital is Heidelberg University Hospital and one of the best clinics in Europe. On 1.05 a biopsy was successfully performed and several samples were taken. The result of the biopsy showed that the tumor was Jung's Sarcoma, one of the most aggressive sarcomas. His treatment included 9 chemotherapy treatments followed by surgery for removal and then 6 more infusions. The treatments began on 05/17/2024.
82000 BGN Paid amount to the beneficiary
1.2 BGN Transaction fee

Strict rules for paying out the donated funds

The PavelAndreev.ORG platform has clearly outlined rules for paying out the donated funds for medical campaigns. They guarantee that all the funds will be used for the respective treatment and related costs. All documents used for payment can be found in the News section.

It's easy to donate

6 easy ways to make your donation - bank card, PayPal, ApplePay, GooglePay, Revolut, IBAN.

View report

In the News section you will find information from the initiators of the campaigns.

Trusted platform

PavelAndreev.ORG is the safest platform to organize your next campaign.